Lifeboat Foundation

July 2019 will see the launch of our second Ending Age-Related Diseases conference at the Frederick P. Rose Auditorium, Cooper Union in New York City. The event was so popular last year that we decided to expand it to two full days of science and biotech business this year.

We will be bringing you the latest aging research, investment, and business knowledge from some of the top experts in the industry. We will be packing two days full of talks from and discussion panels with the people who are developing the technologies that could change the way we regard and treat aging forever.

With just over a month left to grab a lower-cost early bird ticket for the event, we thought that it would be a good opportunity to take a look at what we have in store. We have already announced lots of inspiring speakers from the research and business sectors of the industry, and here are just a few of them.

Continue reading “Ending Age-Related Diseases Conference: February Update” »

Researchers in the US have built an “alien” DNA system from eight building block letters, so expanding the genetic code from four and doubling its information density. The new system meets all of the requirements for Darwinian evolution and can also be transcribed to RNA. It will be important for future synthetic biology applications and expands the scope of molecular structures that might be capable of supporting life, both here on Earth and more widely in the universe.

One of the main characteristics of life is that it can store and pass on genetic information. In modern-day organisms, this is done by DNA using just four building blocks: guanine, cytosine, adenine and thymine (G, A, C and T). Pairs of DNA strands form a double helix with A bonding to T and C bonding to G.

Four more building blocks .

Because there’s not yet an FDA-approved version of this treatment, most medical providers don’t yet offer it. So most patients can get it only by enrolling in research studies, of which there have been dozens in recent years.

Patients Find Relief For Food Allergies In Oral Immunotherapy Treatment : Shots — Health News Many parents of kids with life-threatening food allergies live with fear, EpiPen in hand. Some are trying oral immunotherapy, a treatment that can help patients build tolerance to foods like peanuts.

Universities and big pharmaceutical companies are unlikely to match those resources. But thanks to cloud computing services offered by Google and other tech giants, the price of computing power continues to drop. Dr. AlQuraishi urged the life-sciences community to shift more attention toward the kind of A.I. work practiced by DeepMind.

Researchers at DeepMind, owned by Google’s parent company, and other companies are applying their powerful A.I. systems to drug discovery research.

NIR BARZILAI HAS a plan. It’s a really big plan that might one day change medicine and health care as we know it. Its promise: extending our years of healthy, disease-free living by decades.

The more researchers learn about metformin, the more it seems like a medieval wonder drug that could extend lifespans in the 21st century.

An immune checkpoint molecule, SA-4-1BB developed for cancer immunotherapy also protects against future development of multiple types of cancer when administered by itself, shows a new study.

The recombinant protein molecule SA-4-1BBL has been used to enhance the therapeutic efficacy of cancer vaccines with success in pre-clinical animal models.

Firstly, it greatly depends on how you define immortality. If you define it as living forever and being indestructible as in a comic book, then, no, it is highly unlikely. However, if you define it in terms of showing no decline in survival characteristics, no increase in disease incidence and no increase in mortality with advancing age, then yes. The first is a science-fiction fantasy; the second is based on real-world biology that evolution has already selected for in certain species. We call this state negligible senescence.

Senescence and negligible senescence

Continue reading “Is Immortality Possible?” »

Researchers have developed a next-generation bionic hand that allows amputees to regain their proprioception. The results of the study, which have been published in Science Robotics, are the culmination of ten years of robotics research.

The next-generation bionic hand, developed by researchers from EPFL, the Sant’Anna School of Advanced Studies in Pisa and the A. Gemelli University Polyclinic in Rome, enables amputees to regain a very subtle, close-to-natural sense of touch. The scientists managed to reproduce the feeling of proprioception, which is our brain’s capacity to instantly and accurately sense the position of our limbs during and after movement – even in the dark or with our eyes closed.

The new device allows patients to reach out for an object on a table and to ascertain an item’s consistency, shape, position and size without having to look at it. The prosthesis has been successfully tested on several patients and works by stimulating the nerves in the amputee’s stump. The nerves can then provide sensory feedback to the patients in real time – almost like they do in a natural hand.

He Jiankui did more than make the twins immune to HIV.